Eugene A. Bauer
Medigen Vaccine Biologics Co.
Dr. Eugene Bauer has been a member of Medgenics Board since March 2001. He is the Lucy Becker Professor (Emeritus) in the School of Medicine at Stanford University, having served as Vice President for Medical Affairs (1997-2001) and Dean of the School of Medicine (1995-2001) at Stanford University and as Chair of the Department of Dermatology at the Stanford University School of Medicine from 1988-1995. Currently, Dr. Bauer is Founder, Chief Medical Officer and a member of the Board of Directors of Dermira, Inc. (Nasdaq: DERM). Dr. Bauer is also immediate-past President & Chief Medical Officer of Peplin, Inc., a position he held from 2008 to December 2009, when Peplin was acquired by LEO Pharma. Prior to Peplin, he was founding Chief Executive Officer of Neosil, Inc., also a development stage pharmaceutical company that was acquired by Peplin, Inc., in 2008. He was a co-founder and emeritus member of the board of directors of Connetics Corporation (Nasdaq: CNCT), a publicly traded, dermatology-focused therapeutics company which was acquired by Steifel Laboratories and later sold to GlaxoSmithKline, Inc.